Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001415889-24-021452

Chief Medical Officer sold 2,000 shares at $40.00 ($80,000)

  • Chief Medical Officer acquired 2,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lizzul Paul F. · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-14 Exercise or conversion : show line 1 in the form 10b5-1 +2,000 $18.50 $37,000 13,618 D
2024-08-14 Sale : show line 2 in the form 10b5-1 −2,000 $40.00 $80,000 11,618 D
Open-market sales · 2,000 sh · avg $40.00 · $80,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-14 Exercise or conversion : show line 3 in the form 10b5-1 Common −2,000 86,500 D
Loading xslF345X05/form4-08162024_080835.xml…